CAPTRUST Financial Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $462K | Buy |
24,766
+3,249
| +15% | +$60.6K | ﹤0.01% | 1779 |
|
2025
Q1 | $412K | Buy |
21,517
+3,004
| +16% | +$57.6K | ﹤0.01% | 1759 |
|
2024
Q4 | $667K | Buy |
18,513
+8,343
| +82% | +$301K | ﹤0.01% | 1455 |
|
2024
Q3 | $431K | Buy |
10,170
+1,647
| +19% | +$69.8K | ﹤0.01% | 1656 |
|
2024
Q2 | $343K | Buy |
8,523
+686
| +9% | +$27.6K | ﹤0.01% | 1732 |
|
2024
Q1 | $278K | Buy |
7,837
+823
| +12% | +$29.1K | ﹤0.01% | 1816 |
|
2023
Q4 | $207K | Buy |
+7,014
| New | +$207K | ﹤0.01% | 2374 |
|
2022
Q3 | – | Sell |
-3,251
| Closed | -$192K | – | 3887 |
|
2022
Q2 | $192K | Sell |
3,251
-2,233
| -41% | -$132K | ﹤0.01% | 1722 |
|
2022
Q1 | $638K | Buy |
5,484
+1,632
| +42% | +$190K | ﹤0.01% | 1036 |
|
2021
Q4 | $580K | Buy |
3,852
+84
| +2% | +$12.6K | ﹤0.01% | 1045 |
|
2021
Q3 | $450K | Sell |
3,768
-43
| -1% | -$5.14K | ﹤0.01% | 1082 |
|
2021
Q2 | $371K | Sell |
3,811
-413
| -10% | -$40.2K | ﹤0.01% | 1134 |
|
2021
Q1 | $373K | Buy |
4,224
+2,122
| +101% | +$187K | ﹤0.01% | 1108 |
|
2020
Q4 | $201K | Buy |
2,102
+1
| +0% | +$96 | ﹤0.01% | 1182 |
|
2020
Q3 | $239K | Buy |
2,101
+51
| +2% | +$5.8K | ﹤0.01% | 959 |
|
2020
Q2 | $203K | Sell |
2,050
-431
| -17% | -$42.7K | ﹤0.01% | 1032 |
|
2020
Q1 | $149K | Buy |
+2,481
| New | +$149K | ﹤0.01% | 966 |
|
2019
Q4 | – | Sell |
-1,155
| Closed | -$68K | – | 1741 |
|
2019
Q3 | $68K | Buy |
1,155
+850
| +279% | +$50K | ﹤0.01% | 905 |
|
2019
Q2 | $20K | Hold |
305
| – | – | ﹤0.01% | 1280 |
|
2019
Q1 | $19K | Buy |
+305
| New | +$19K | ﹤0.01% | 1182 |
|